Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioid overdose, the health regulator said.
from Reuters: Health https://reut.rs/2ILi92z
No comments:
Post a Comment